Clinical Value of Timely Targeted Therapy for Patients With Advanced Non-Small Cell Lung Cancer With Actionable Driver Oncogenes.
Stricker T, Jain N, Ma E, Yu E, Wang R, Schuldt R, Price R, Szado T, Sussell J, Ogale S, Lin V, Arrowsmith E, Slater D, Vaena D, Staszewski H, Fang B, Seneviratne L, Daniel D.
Stricker T, et al. Among authors: szado t.
Oncologist. 2024 Feb 28:oyae022. doi: 10.1093/oncolo/oyae022. Online ahead of print.
Oncologist. 2024.
PMID: 38417095
Free article.